Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BLUE BIOFUELS, INC. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being handled by 1 distinct examiner within 1 distinct art unit. The company's current prosecution activity is limited to this single technical field. Practitioners should analyze the specific allowance rates and trends of this 1 distinct art unit to optimize their response strategy. The concentration of the portfolio suggests that the company is focusing its intellectual property efforts on a specific biological or pharmaceutical innovation.
The busiest examiner for the portfolio is RAGHU, GANAPATHIRAM, who is currently managing 1 pending office action. This accounts for the total number of pending office actions for the company. Having 1 distinct examiner and 1 distinct art unit means that the prosecution process is centralized. This allows for a targeted approach when addressing the requirements of the patent office. The workload of 1 busiest examiner pending 1 matter indicates that the company is currently focused on a single active application. This streamlined prosecution environment reduces the complexity of managing multiple examiner interviews or conflicting art unit requirements.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAGHU, GANAPATHIRAM | 1 | 73.6% | +26.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274138 | SYSTEM AND METHOD TO CREATE A WATER-SOLUBLE MIXTURE OF OLIGOSACCHARIDES FOR FACILE CONVERSION TO FERMENTABLE SUGARS | RAGHU, GANAPATHIRAM | 62d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274138 | SYSTEM AND METHOD TO CREATE A WATER-SOLUBLE MIXTURE OF OLIGOSACCHARIDES FOR FACILE CONVERSION TO FERMENTABLE SUGARS | RAGHU, GANAPATHIRAM | 62d |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18274138 | SYSTEM AND METHOD TO CREATE A WATER-SOLUBLE MIXTURE OF OLIGOSACCHARIDES FOR FACILE CONVERSION TO FERMENTABLE SUGARS | RAGHU, GANAPATHIRAM | 1652 | §103§112Other | Final Rejection | 62d | Pending | Jul 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial